Related Experiment Video
Updated: Jul 12, 2026
07:22
Quantifying Single Microvessel Permeability in Isolated Blood-perfused Rat Lung Preparation
Published on: June 30, 2014
Age-dependent propranolol clearance in perfused rat liver
Biochemical Pharmacology
|April 1, 1986
Summary
Liver drug clearance of propranolol changes with age. Young rats (5-7 weeks) show the highest hepatic clearance, while immature and older rats exhibit significantly lower clearance rates.
Area of Science:
- Pharmacology
- Hepatology
- Gerontology
Background:
- Hepatic clearance is crucial for drug metabolism and elimination.
- Age-related changes in liver function can significantly impact drug pharmacokinetics.
- Understanding these changes is vital for optimizing drug therapy across different age groups.
Purpose of the Study:
- To investigate the effect of aging on the hepatic clearance of propranolol in rats.
- To determine the relationship between rat age and the efficiency of propranolol metabolism by the liver.
- To characterize the age-dependent profile of hepatic drug clearance.
Main Methods:
- Isolated rat liver perfusion technique was employed across a wide age range (3 to 104 weeks).
- Propranolol was used as a model drug to assess hepatic clearance (CLperf).
- Perfusion flow rate and drug concentration were controlled to evaluate clearance limitations and dose-dependence.
Main Results:
- Hepatic clearance of propranolol was confirmed to be perfusion-limited in 7-week-old rats.
- The highest hepatic clearance (CLperf) was observed in young adult rats (5-7 weeks old), reaching approximately 1.0-1.1 ml x min-1 x (g liver)-1.
- Both immature (younger) and aged (104-week-old) rats demonstrated significantly lower CLperf values (≤0.5 ml x min-1 x (g liver)-1).
- In vitro intrinsic hepatic clearance was approximately tenfold higher in 5- and 7-week-old rats compared to 104-week-old rats.
Conclusions:
- Liver drug metabolism efficiency, specifically propranolol clearance, is significantly influenced by age in rats.
- Young adult rats exhibit optimal hepatic clearance, suggesting peak liver metabolic capacity during this life stage.
- Aging leads to a marked decline in hepatic drug clearance, highlighting potential challenges in drug efficacy and safety for older individuals.
Related Concept Videos
01:15Factors Affecting Drug Distribution: Organ Perfusion Rate
Drug distribution within the body is a complex process influenced by several factors, including perfusion rate, the rate at which the bloodstream transports drugs to tissue. This limitation becomes particularly significant when dealing with highly lipophilic drugs. In such cases, the rate at which the drug can move across membranes is crucial, and if the membrane is highly permeable to the drug, distribution becomes rate-limited by perfusion.
Perfusion rate-limited distribution relies on the...
Perfusion rate-limited distribution relies on the...
01:09Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
01:09Hepatic Drug Clearance: Effect of Protein Binding
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...